Proteostasis Therapeutics is discovering and developing novel small molecule therapeutics designed to control the bodyâ€™s protein homeostasis, or Proteostasis Network. The Proteostasis Network maintains the bodyâ€™s natural balance of proteins to protect us from numerous diseases. These novel therapies, or Proteostasis Regulators, are designed to treat multiple genetic and degenerative disorders associated with deficiencies of the Proteostasis Network, such as emphysema, type II diabetes, Alzheimerâ€™s Disease and Huntingtonâ€™s Disease.
Funding Rounds (2) - $73.6MUpdate
Board Members and Advisors (3)Update
Sanofi-Genzyme BioVentures (SGBV) is an important component of Sanofi’s broader global strategy...
Venture capital Firm
Global venture capital firm helping entrepreneurs build transformational businesses across...
They are a division of Fidelity Investments, one of the worldâ€™s leading providers of financial...
790 Memorial Drive, Suite 103
Cambridge, MA 02139